Pharmacological characterization of the imipridone anti-cancer drug ONC201 reveals a negative allosteric mechanism of action at the D2 dopamine receptor https://t.co/luchf6SGqn
Excited to share a new paper featuring the work of Despoina Aslanoglou and our many great collaborators! Pancreatic alpha cells & beta cells make dopamine to control insulin & glucagon release!
#diabetes#insulin@PittResearch@PittPsychiatry@UPittEndo
https://t.co/HUkvx7T4od
Discovery and optimization of a selective D3 dopamine receptor agonist, ML417, as a therapeutic lead for neurological disorders @NIH @NINDSnews @UNCPharmacy@ncats_nih_gov@NIDAnews :
https://t.co/jrwPRsxMGi
@keck_lab@TheCalipariLab ACS now has a 'certified reviewer course' - if you take it / recommend to your students, they seem to send you a lot of reviews https://t.co/45aIKxazkj